State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells

Peptides

Volumn 29, Issue 5, 2008, Pages 721-726

  Brailoiu, Eugen ^a   Jiang, Xiaohua ^a   Brailoiu, G Cristina ^a   Yang, Jun ^b   Chang, Jaw Kang ^b   Wang, Hong ^a   Dun, Nae J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHOENIX PHARMACEUTICALS INC   (United States)

Author keywords

Calcium mobilization; G protein coupled receptor; Human endothelial cells

Indexed keywords

CALCIUM ION; UROTENSIN II;

AORTA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; DESENSITIZATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROFLUOROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; SHEAR STRENGTH; THROMBIN; UROTENSINS;

EID: 42049107090     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.12.019     Document Type: Article

References (62)

1. Adams D.J., Barakeh J., Laskey R., and Van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 3 (1989) 2389-2400
2. Aiyar N., Johns D.G., Ao Z., Disa J., Behm D.J., Foley J.J., et al. Cloning and pharmacological characterization of the cat urotensin-II receptor (UT). Biochem Pharmacol 69 (2005) 1069-1079
3. Abdelrahman A.M., and Pang C.C.Y. Involvement of the nitric oxide/l-arginine and sympathetic nervous systems on the vasodepressor action of human urotensin II in anesthetized rats. Life Sci 71 (2002) 819-825
4. Affolter J.T., Newby D.E., Wilkinson L.B., Winter M.J., Balment R.J., and Webb D.J. No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans. Br J Clin Pharmacol 54 (2002) 617-621
5. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
6. Baker K.M., and Kumar R. Intracellular angiotensin II induces cell proliferation independent of AT1 receptor. Am J Physiol Cell Physiol 291 (2006) C995-C1001
7. Bennett R.T., Jones R.D., Morice A.H., Smith C.F., and Cowen M.E. Vasoconstrictive effects of endothelin-1, endothelin-3, and urotensin II in isolated perfused human lungs and isolated human pulmonary arteries. Thorax 59 (2004) 401-407
8. Bhagyalakshmi A., Berthiaume F., Reich K.M., and Frangos J.A. Fluid shear stress stimulates membrane phospholipids metabolism in cultured human endothelial cells. J Vasc Res 29 (1992) 443-449
9. Bird R.B., Stewart W.E., and Lightfoot E.N. Transportation Phenomena (1960), John Wiley & Sons, Inc., New York
10. Bohm F., and Pernow J. Urotensin II evokes potent vasoconstriction in humans in vivo. Br J Pharmacol 135 (2002) 25-27
11. Bottrill F.E., Douglas S.A., Hiley C.R., and White R. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 130 (2000) 1865-1870
12. Brailoiu E., Brailoiu G.C., Miyamoto M.D., and Dun N.J. The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals. Br J Pharmacol 138 (2003) 1580-1588
13. Brailoiu E., Filipeanu C.M., Tica A., Toma C.P., de Zeeuw D., and Nelemans S.A. Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta. Br J Pharmacol 126 (1999) 1133-1138
14. Brailoiu E., Churamani D., Pandey V., Brailoiu G.C., Tuluc F., Patel S., et al. Messenger-specific role for nicotinic acid adenine dinucleotide phosphate in neuronal differentiation. J Biol Chem 281 (2006) 15923-15928
15. Camarda V., Rizzi A., Calo G., Gendron G., Perron S.I., Kostenis E., et al. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents. Naunyn Schmiedebergs Arch Pharmacol 365 (2002) 141-149
16. Castel H., Diallo M., Chatenet D., Leprince J., Desrues L., Schouft M.T., et al. Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J Neurochem 99 (2006) 582-595
17. Chartrel N., Leprince J., Dujardin C., Chatenet D., Tollemer H., Baroncini M., et al. Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. J Neurochem 91 (2004) 110-118
18. Chatenet D., Dubessy C., Boularan C., Scalbert E., Pfeiffer B., Renard P., et al. Structure-activity relationships of a novel series of urotensin II analogues: identification of urotensin II antagonists. J Med Chem 49 (2006) 7234-7238
19. Conlon J.M. Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research. Regul Pept 93 (2000) 3-12
20. Coulouarn Y., Jégou S., Tostivint H., Vaudry H., and Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS 457 (1999) 28-32
21. Coulouarn Y., Lihrmann I., Jégou S., Anouar Y., Tostivint H., Beauvillain J.C., et al. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95 (1998) 15803-15808
22. Coughlin S.R. Thrombin signalling and protease-activated receptors. Nature 407 (2000) 258-264
23. D'Amore P., and Shepro D. Stimulation of growth and calcium influx in cultured, bovine, aortic endothelial cells by platelets and vasoactive substances. J Cell Physiol 92 (1977) 177-183
24. Do-Rego J.C., Chatenet D., Orta M.H., Naudin B., Le Cudennec C., Leprince J., et al. Behavioral effects of urotensin-II centrally administered in mice. Psychopharmacology 183 (2005) 103-117
25. Douglas S.A., Ashton D.J., Sauermelch C.F., Coatney R.W., Ohlstein D.H., Ruffolo M.R., et al. Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate. J Cardiovasc Pharmacol 36 (2000) S163-S166
26. Douglas S.A., Sulpizio A.C., Piercy V., Sarau H.M., Ames R.S., Aiyar N.V., et al. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 131 (2000) 1262-1274
27. Douglas S.A., Naselsky D., Ao Z., Disa J., Herold C.L., Lynch F., et al. Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. Br J Pharmacol 142 (2004) 921-932
28. Dun S.L., Brailoiu G.C., Yang J., Chang J.K., and Dun N.J. Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci Lett 305 (2001) 9-12
29. Egginger J.G., Camus A., and Calas A. Urotensin-II expression in the mouse spinal cord. J Chem Neuroanat 31 (2006) 146-154
30. Filipeanu C.M., Brailoiu E., Dun S.L., and Dun N.J. Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons. J Neurochem 83 (2002) 879-884
31. Gartion J., Parker F., Harrison D.C., Douglas S.A., Ashmeade T.E., Riley G.J., et al. Central effects of urotensin-II following ICV administration in rats. Psychopharmacology 155 (2001) 426-433
32. Gibson A. Complex effects of Gillichthys urotensin II on rat aortic strips. Br J Pharmacol 91 (1987) 205-212
33. Haller H., Lindschau C., Erdmann B., Quass P., and Luft F.C. Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res 79 (1996) 765-772
34. Hillier C., Berry C., Petrie M.C., O'Dwyer P.J., Hamilton C., Brown A., et al. Effects of urotensin II in human arteries and veins of varying caliber. Circulation 103 (2001) 1378-1381
35. Himmel H.M., Whorton A.R., and Strauss H.C. Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. Hypertension 21 (1993) 112-127
36. Huitron-Resendiz S., Kristensen M.P., Sánchez-Alavez M., Clark S.D., Grupke S.L., Tyler C., et al. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 25 (2005) 5465-5474
37. Itoh Y., Sendo T., and Oishi R. Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function. J Pharmacol Sci 97 (2005) 14-19
38. James N.L., Harrison D.G., and Nerem R.M. Effects of shear on endothelial cell calcium in the presence and absence of ATP. FASEB J 9 (1995) 968-973
39. Jegou S., Cartier D., Dubessy C., Gonzalez B.J., Chatenet D., Tostivint H., et al. Localization of the urotensin II receptor in the rat central nervous system. J Comp Neurol 495 (2006) 21-26
40. Lansman J.B., Hallam T.J., and Rink T.J. Single stretch-activated ion channel in vascular endothelial cells as mechanotrasducers?. Nature 325 (1987) 811-813
41. Lin L., Ding W.H., Jiang W., Zhang Y.G., Qi Y.F., Yuan W.J., et al. Urotensin-II activates l-arginine/nitric oxide pathway in isolated rat aortic adventitia. Peptides 25 (2004) 1977-1984
42. Liu Q., Pong S.S., Zeng Z., Zhang Q., Howard A.D., Williams Jr. D.L., et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266 (1999) 174-178
43. Matsushita M., Shichiri M., Imai T., Iwashina M., Tanaka H., Takasu N., et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19 (2001) 2185-2190
44. Mori M., Sugo T., Abe M., Shimomura Y., Kurihara M., Kitada C., et al. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265 (1999) 123-129
45. Nilius B. Signal transduction in vascular endothelium: the role of intracellular calcium and ion channels. Verh K Acad Geneeskd Belg 60 (1998) 215-250
46. Nollert M.U., Eskin S.G., and McIntire L.V. Shear stress increases inositol triphosphate levels in human endothelial cells. Biochem Biophys Res Commun 10 (1990) 281-287
47. Nothacker H.P., Wang Z., McNeill A.M., Saito Y., Merten S., O'Dowd B., et al. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1 (1999) 383-385
48. Olsen S.P., Clapham D.E., and Davies P.F. Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 331 (1988) 168-170
49. Pelletier G., Lihrmann I., and Vaudry H. Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord. Neuroscience 115 (2002) 525-532
50. Pelletier G., Lihrmann I., Dubessy C., Luu-The V., Vaudry H., and Labrie F. Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience 132 (2005) 689-696
51. 2+ oscillations: frequency encoding and identification of underlying feedbacks. Biophys J 90 (2006) 3120-3133
52. Qi J.S., Schulingkamp R., Parry T.J., Colburn R., Stone D., Haertlein B., et al. Urotensin-II induces ear flushing in rats. Br J Pharmacol 150 (2007) 415-423
53. Pirotton S., Communi D., Motte S., Janssens R., and Boeynaems J.M. Endothelial P2-purinoceptors: subtypes and signal transduction. J Auton Pharmacol 16 (1996) 353-356
54. Pearson D., Shively J.E., Clark B.R., Geschwind I.I., Barkley M., Nishioka R.S., et al. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77 (1980) 5021-5024
55. Rossowski W.J., Cheng B.L., Taylor J.E., Datta R., and Coy D.H. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol 438 (2002) 159-170
56. Saetrum-Opgaard O., Nothacker H., Ehlert F.J., and Krause D.N. Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur J Pharmacol 406 (2000) 265-271
57. Schwarz G., Callewaert G., Droogmans G., and Nilus B. Shear stress-induced calcium transients in endothelial cells from human umbilical cord veins. J Physiol (London) 458 (1992) 527-538
58. Shen J., Luscinskas F.W., Connolly A., Dewey C.F., and Gimbrone M.A. Fluid shear stress modulates cytosolic free calcium in vascular endothelial cells. Am J Physiol 262 (1992) C384-C390
59. Stirrat A., Gallagher M., Douglas S.A., Ohlstein E.H., Berry C., Kirk A., et al. Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Circ Physiol 280 (2001) H925-H928
60. Viana F., de Smedt H., Droogmans G., and Nilius B. Calcium signalling through nucleotide receptor P2Y2 in cultured human vascular endothelium. Cell Calcium 24 (1998) 117-127
61. Watanabe T., Koba S., Katagiri T., Pakala R., and Benedict C.R. Lysophosphatidylcholine potentiates the mitogenic effect of various vasoactive compounds on rabbit aortic smooth muscle cells. Jpn Heart J 43 (2002) 409-416
62. Zhang A.Y., Chen Y.F., Zhang D.X., Yi F.X., Qi J., Andrade-Gordon P., et al. Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. Am J Physiol Renal Physiol 285 (2003) F792-F798